biomarin
BioMarin is seeking a Scientist II with expertise in bioconjugation chemistry to design and synthesize complex biomolecules such as antibody-drug and antibody-oligo conjugates. The role involves developing conjugation methods, characterizing products with analytical techniques, and collaborating with cross‑functional teams to support preclinical and clinical programs.
Headquarters
San Rafael, California, United States
Company Size
1001-5000 employees
Founded
1997
BioMarin Pharmaceutical is a global biotechnology company that researches, develops, and commercializes therapies for rare genetic and lysosomal storage diseases. The company has brought medicines to market for conditions such as achondroplasia and severe hemophilia A and focuses on innovative modalities—including gene therapies and biologics—to address high unmet medical needs. BioMarin partners with clinicians, regulators, and patient communities to advance treatments from discovery through global regulatory approval and patient access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biomarin.
biomarin didn’t post a salary, so this is our estimate from similar listings.
78% above the average for this role
Organic and Conjugation Chemist
Amgen
Bioconjugation Scientist
NJ BIO INC
Research Associate II, Oligonucleotide Synthesis
CRISPR Therapeutics
Associate Director, Bioconjugation & Delivery
Alloy Therapeutics
Research Fellow in Organic Chemistry
Nanyang Technological University
Organic and Conjugation Chemist
Amgen